Annual Short Term Debt
$464.00 K
-$4.59 M-90.83%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual short term debt is $464.00 thousand, with the most recent change of -$4.59 million (-90.83%) on December 31, 2023.
- During the last 3 years, CTNM annual short term debt has fallen by -$786.00 thousand (-62.88%).
- CTNM annual short term debt is now -90.83% below its all-time high of $5.06 million, reached on December 31, 2022.
Performance
CTNM Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$611.00 K
+$127.00 K+26.24%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly short term debt is $611.00 thousand, with the most recent change of +$127.00 thousand (+26.24%) on September 30, 2024.
- Over the past year, CTNM quarterly short term debt has increased by +$147.00 thousand (+31.68%).
- CTNM quarterly short term debt is now -87.92% below its all-time high of $5.06 million, reached on December 1, 2022.
Performance
CTNM Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
CTNM Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.8% | +31.7% |
| 3 y3 years | -62.9% | -87.9% |
| 5 y5 years | -62.9% | -87.9% |
CTNM Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | at low | -87.9% | +31.7% |
| 5 y | 5-year | -90.8% | at low | -87.9% | +31.7% |
| alltime | all time | -90.8% | at low | -87.9% | +31.7% |
Contineum Therapeutics Class A Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $611.00 K(+26.2%) |
| Jun 2024 | - | $484.00 K(+2.1%) |
| Mar 2024 | - | $474.00 K(+2.2%) |
| Dec 2023 | $464.00 K | $464.00 K(-58.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.12 M(-77.8%) |
| Dec 2022 | $5.06 M(+304.6%) | - |
| Dec 2022 | - | $5.06 M |
| Dec 2021 | $1.25 M | - |
FAQ
- What is Contineum Therapeutics Class A annual short term debt?
- What is the all time high annual short term debt for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual short term debt year-on-year change?
- What is Contineum Therapeutics Class A quarterly short term debt?
- What is the all time high quarterly short term debt for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly short term debt year-on-year change?
What is Contineum Therapeutics Class A annual short term debt?
The current annual short term debt of CTNM is $464.00 K
What is the all time high annual short term debt for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual short term debt is $5.06 M
What is Contineum Therapeutics Class A annual short term debt year-on-year change?
Over the past year, CTNM annual short term debt has changed by -$4.59 M (-90.83%)
What is Contineum Therapeutics Class A quarterly short term debt?
The current quarterly short term debt of CTNM is $611.00 K
What is the all time high quarterly short term debt for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly short term debt is $5.06 M
What is Contineum Therapeutics Class A quarterly short term debt year-on-year change?
Over the past year, CTNM quarterly short term debt has changed by +$147.00 K (+31.68%)